The designation was granted to Emerald Health Pharmaceuticals’ EHP-101, an oral formulation of a novel aminoquinone synthetic derivative of cannabidiol endowed with dual peroxisome proliferator-activated receptor gamma and cannabinoid receptor type 2 agonist activity.
The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.
Pharmacy Times® will publish a technician supplement in July 2020.
The National Community Pharmacists Association, the Arkansas Pharmacists Association, the American Pharmacists Association, and the National Alliance of State Pharmacy Associations took the joint action of filing an amicus brief in the Supreme Court case [Arkansas Attorney General Leslie] Rutledge v. the Pharmaceutical Care Management Association, scheduled to be heard in Washington, DC on April 27, 2020.
Specialty pharmacies can provide seamless support across specialty mail and retail channels.
The greatest risk is still to people who have been in close contact with COVID-19 patients, according to the CDC.
The drug also received orphan drug designation.
There is countless research that highlights the skills and value technicians provide as pharmacy support staff.
This approval marks the first for combination ibuprofen and acetaminophen for OTC use.
Why is a patient taking cimetidine for warts?
Children aged 0 to 4 years are now the highest CDC has on record at this point in the season, surpassing the rates reported during the second wave of the 2009 H1N1 pandemic.
This is one of the first US population-based studies to compare overdose risk among 2 patient populations across an entire state.
If severe, toxoplasmosis can cause damage to the brain, eyes, or other organs.
The virus has now reached all continents except Antarctica, with cases reported in 47 countries.
Depending on the amount consumed, intake of dairy milk can increase the risk of breast cancer by up to 80%, according to new research from Loma Linda University Health.
Top News of the Week from Directions in Specialty Pharmacy.
The medication works by blocking CGRP receptors, treating a root cause of migraine.
As health care costs continue to rise in the United States, crowdfunding on websites such as GoFundMe is becoming increasingly common.
Researchers report promising activity with a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease.
Ancient Egyptians wrote some of the oldest pharmaceutical records, including prescriptions. How many centuries ago do some of the oldest records date back to?
As pharmacists, patients are inquiring about these kits already, and recommending such items can help prevent a lot of worry.
According to a new report from the Leonard D. Schaeffer Center for Health Policy and Economics, a $1 increase in drug rebates was associated with a $1.17 rise in list prices, hurting uninsured patients who pay list prices and insured patients who pay coinsurance and deductibles based on list prices.
In order to increase the effectiveness of adherence interventions, we need to take into account the fact that human beings are not always rational.
This is the first newly approved therapy for high risk locally advanced squamous cell carcinoma of LA-SCCHN in 25 years.
Bempedoic acid and ezetimibe combined is the first non-statin, LDL-C lowering combination medicine ever approved, according to Esperion.
Top news from across the health care landscape.
Two recently approved leukemia drugs could be enlisted against treatment-resistant lung cancer.
Officials from the FDA have approved a supplemental New Drug Application (sNDA) for neratinib (NERLYNX, Puma Biotechnology) in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer that have received 2 or more prior anti-HER2-based regimens in the metastatic setting.
Four FDA-approved products that face no competition may increase health care spending by as much as $20.25 billion, according to a new analysis by Vizient Inc.1
In the matter of California State Board of Pharmacy vs Pacifica Pharmacy and Thang Tran, action was taken by the board against a pharmacist accused of poor oversight, and judgment over occurrences at a community pharmacy under his watch.
